Thomas Gutshall - Cepheid Director
Director
Mr. Thomas L. Gutshall is an Independent Director of Cepheid. Mr. Gutshall is a cofounder of Cepheid. He served as Chairman of the Board from August 1996 until January 2013. From August 1996 until April 2002 he also served as our Chief Executive Officer. From January 1995 to August 1996 he was President and Chief Operating Officer of CV Therapeutics and served on its board of directors for fourteen years. From 1989 to 1994 he was Executive Vice President at Syntex Corporation and a member of the Pharmaceutical Executive Committee. His responsibilities while at Syntex included managing Syva Company Syntex Agribusiness Pharmaceutical and Chemical Operations and Services Syntex Pharmaceutical Intl. Ltd. and Environmental Health and Safety. Mr. Gutshall currently serves as a director of Silver Bullet Therapeutics Inc. and PROFUSA Inc. As a founder and former chief executive officer of Cepheid as well as an executive and director of other life sciences businesses and organizations Mr. Gutshall contributes his deep experience with our proprietary technologies and broader industry trends and best practices. since 2013.
| Age | 76 |
| Tenure | 11 years |
| Phone | 408 541-4191 |
| Web | www.cepheid.com |
Cepheid Management Efficiency
The company has return on total asset (ROA) of (0.0746) % which means that it has lost $0.0746 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (16.6296) %, meaning that it created substantial loss on money invested by shareholders. Cepheid's management efficiency ratios could be used to measure how well Cepheid manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 281.63 M in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Cepheid has a current ratio of 4.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cepheid until it has trouble settling it off, either with new capital or with free cash flow. So, Cepheid's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cepheid sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cepheid to invest in growth at high rates of return. When we think about Cepheid's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Robert Polet | Relx PLC ADR | 59 | |
| Linda Sanford | Relx PLC ADR | 68 | |
| Catherine Reynolds | Lindblad Expeditions Holdings | 60 | |
| Piyush Sodha | Lindblad Expeditions Holdings | 56 | |
| Dyson Dryden | Lindblad Expeditions Holdings | 42 | |
| Hans Norkus | Acco Brands | 73 | |
| Gaoneng Ji | Sunlands Technology Group | 31 | |
| Daniel Hanrahan | Lindblad Expeditions Holdings | 60 | |
| Kathleen Dvorak | Acco Brands | 64 | |
| Harvey Eads | Visionary Education Technology | 73 | |
| Adrian Hennah | Relx PLC ADR | 60 | |
| Lawrence Calcano | Lindblad Expeditions Holdings | 53 | |
| Lv Lu | Sunlands Technology Group | 35 | |
| Stephen Appel | Visionary Education Technology | 64 | |
| Julie ONeill | Ryanair Holdings PLC | 62 | |
| Declan McKeon | Ryanair Holdings PLC | 66 | |
| Stan McCarthy | Ryanair Holdings PLC | 59 | |
| Richard Donaldson | Lindblad Expeditions Holdings | 56 | |
| Sam Sun | Sunlands Technology Group | 44 | |
| John White | Universal Technical Institute | 70 | |
| Emer Daly | Ryanair Holdings PLC | 54 | |
Management Performance
| Return On Equity | -16.63 | |||
| Return On Asset | -0.0746 |
Cepheid Leadership Team
Elected by the shareholders, the Cepheid's board of directors comprises two types of representatives: Cepheid inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cepheid. The board's role is to monitor Cepheid's management team and ensure that shareholders' interests are well served. Cepheid's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cepheid's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Gutshall, Co-Founder, Director, Member of Nominating and Governance Committee and Member of Compensation and Organizational Devel. Committee | ||
| Robert Easton, Independent Director | ||
| Glenn Steele, Independent Director | ||
| Thomas Brown, Independent Director | ||
| Warren Kocmond, COO and Executive VP | ||
| Jacquie Ross, IR Contact Officer | ||
| Kerry Flom, Chief Regulatory Officer and Executive VP | ||
| Daniel Madden, Vice President Corporate Controller and Acting CFO | ||
| Michael Fitzgerald, Executive VP of Global HR | ||
| Peter Farrell, Executive VP of Worldwide Commercial Operations | ||
| David Persing, Executive Vice President Chief Medical and Technology Officer, Director | ||
| Scott Campbell, Corporate Vice President , Chief Regulatory Officer | ||
| Marc Haugen, Executive Vice President - Engineering and Operations | ||
| John Bishop, Chairman, CEO and Member of Equity Incentive Committee | ||
| Cristina Kepner, Lead Independent Director | ||
| Hollings Renton, Independent Director | ||
| Joseph Smith, Executive Vice President - Corporate Development, General Counsel |
Cepheid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cepheid a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -16.63 | |||
| Return On Asset | -0.0746 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (2.81) % | |||
| Current Valuation | 2.79 B | |||
| Shares Outstanding | 71.93 M | |||
| Shares Owned By Insiders | 1.74 % | |||
| Shares Owned By Institutions | 98.26 % | |||
| Number Of Shares Shorted | 2.61 M | |||
| Price To Earning | 910.67 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cepheid in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cepheid's short interest history, or implied volatility extrapolated from Cepheid options trading.
Pair Trading with Cepheid
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cepheid position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cepheid will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Progressive Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Progressive Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Progressive Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Progressive Corp to buy it.
The correlation of Progressive Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Progressive Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Progressive Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Progressive Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Cepheid information on this page should be used as a complementary analysis to other Cepheid's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Cepheid Stock
If you are still planning to invest in Cepheid check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cepheid's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |